Psilocybe Cubensis
Psilocybe cubensis
Psilocybe cubensis is a species of psychedelic mushroom in the family Hymenogastraceae, belonging to the phylum Basidiomycota. It is one of the most well-known and widely distributed psilocybin-containing fungi in the world.
This species has played a significant role in ethnomycology, neuroscience research, and human cultural history for millennia. Its distinctive appearance and potent psychoactive properties have made it one of the most studied fungi in modern science.
• Contains the psychoactive compounds psilocybin and psilocin
• Classified as a "magic mushroom" due to its hallucinogenic effects
• Has been used in indigenous Mesoamerican spiritual rituals for thousands of years
• The genus name Psilocybe derives from the Greek "psilos" (bald) and "kybe" (head), referring to the smooth, bare cap surface
Taxonomy
• Native range includes Central America, the Caribbean, Southeast Asia, parts of South America, and the southeastern United States (particularly Florida, Louisiana, and Texas)
• Also found in Australia, India, and various Pacific islands
• First scientifically described by American mycologist Franklin Sumner Earle in 1906 from specimens collected in Cuba — hence the species epithet "cubensis"
• Archaeological evidence (mushroom stones from Guatemala and Mexico) suggests human use of Psilocybe species dating back to at least 1000–500 BCE in Mesoamerican cultures
Cap (Pileus):
• 1.5–8 cm in diameter
• Shape: initially conical to bell-shaped (campanulate), becoming broadly convex to nearly flat with age
• Color: golden-brown to chestnut-brown when moist, fading to pale straw-yellow or buff as it dries
• Surface: smooth, slightly sticky or gelatinous when wet; often with a separable gelatinous pellicle
• Margin: incurved when young, becoming straight or slightly uplifted; occasionally bearing remnants of the partial veil
• Staining: flesh and cap surface bruise blue to bluish-green when damaged (due to oxidation of psilocin) — a key diagnostic feature
Gills (Lamellae):
• Adnate to sinuate attachment to the stipe
• Close to crowded spacing
• Color: initially pale grayish or purplish, maturing to dark purple-brown to nearly black as spores mature
• Gill edges remain whitish
Stipe (Stem):
• 4–15 cm long, 0.4–1.5 cm thick
• Cylindrical, often slightly thicker at the base
• Color: white to pale yellowish
• Surface: smooth to slightly fibrous; bruises blue when handled
• Bears a thin, membranous partial veil that often leaves a fragile ring (annulus) on the upper stipe
• Base may have white rhizomorphic mycelium
Spores:
• Spore print: dark purple-brown to nearly black
• Individual spores: ellipsoid to subrhomboid, smooth-walled, 11–17 × 7–12 μm
• Possess a broad germ pore
Flesh:
• Thin, whitish to pale yellowish
• Stains blue upon bruising or cutting
Habitat:
• Primarily found growing on dung of herbivorous animals (especially cattle and water buffalo)
• Also colonizes dung-enriched soil, compost, and well-manured grasslands
• Thrives in tropical and subtropical climates with warm, humid conditions
• Fruiting season: year-round in tropical regions; primarily late spring through autumn in subtropical areas
Substrate Preferences:
• Coprophilous (dung-loving) — most commonly found directly on cow patties and horse manure
• Also grows on decaying plant debris in fertilized pastures and gardens
• Requires nutrient-rich, nitrogen-abundant substrates
Environmental Conditions:
• Optimal fruiting temperature: 24–30°C
• Requires high humidity (>80% relative humidity) for fruiting
• Fruits prolifically after heavy rains in warm weather
• Often appears in clusters (cespitose) or scattered groups
Distribution:
• Pantropical distribution — found across tropical and subtropical zones worldwide
• Most abundant in Southeast Asia (Thailand, Cambodia, Vietnam, Indonesia), Central America, the Caribbean, and the Gulf Coast of the United States
• Also reported in parts of South America, Australia, and southern Africa
Active Compounds:
• Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) — the primary psychoactive compound
• Psilocin (4-hydroxy-N,N-dimethyltryptamine) — the dephosphorylated active metabolite
• Baeocystin and norbaeocystin — minor related tryptamine alkaloids
Psilocybin Content:
• Typically 0.37–1.30% psilocybin by dry weight (varies by strain, growing conditions, and substrate)
• Psilocin content: typically 0.14–0.42% by dry weight
• Baeocystin: trace amounts up to ~0.36%
Pharmacology:
• Psilocybin is rapidly dephosphorylated to psilocin in the body
• Psilocin acts primarily as a partial agonist at serotonin 5-HT2A receptors
• Effects include altered perception, visual and auditory hallucinations, synesthesia, emotional intensification, and altered sense of time
• Onset of effects: typically 20–60 minutes after oral ingestion
• Duration: 4–6 hours depending on dose and individual metabolism
Toxicity Profile:
• Physically, psilocybin mushrooms have very low acute toxicity
• LD50 in animal studies is extremely high relative to psychoactive doses
• No confirmed cases of fatal overdose from psilocybin alone in the medical literature
• Primary risks are psychological: panic reactions, dangerous behavior during intoxication, and potential triggering of latent psychiatric conditions (particularly in individuals with personal or family history of psychotic disorders)
• The blue-bruising reaction is caused by enzymatic oxidation of psilocin and is not itself an indicator of toxicity
Legal Status:
• Psilocybin and psilocin are classified as Schedule I controlled substances under the United Nations Convention on Psychotropic Substances (1971)
• Illegal to possess, cultivate, or distribute in most countries worldwide
• Some jurisdictions have recently decriminalized or permitted therapeutic use (e.g., Oregon, USA; parts of Australia for treatment-resistant depression)
Substrate:
• Pasteurized straw, coconut coir, vermiculite mixes (PF Tek method)
• Supplemented hardwood sawdust
• Composted manure-based substrates (most natural and productive)
• Grain spawn (rye berries, millet, or wheat) used for inoculation
Growing Conditions:
• Colonization temperature: 27–30°C
• Fruiting temperature: 22–27°C
• Humidity: 85–95% relative humidity during fruiting
• Fresh air exchange (FAE) is critical during fruiting to prevent CO2 buildup
• Light: indirect light or ambient room light is sufficient to trigger pinning (not required for photosynthesis, but acts as a fruiting trigger)
Cultivation Process:
• Spores are germinated on sterile agar or injected into sterilized grain jars
• Mycelium colonizes the grain spawn over 2–4 weeks
• Spawn is transferred to bulk substrate in a fruiting container
• Fruiting bodies (mushrooms) typically appear 1–3 weeks after spawning to bulk substrate
• Multiple flushes (harvests) can be obtained from a single substrate block
Common Cultivated Strains:
• Golden Teacher, B+, Penis Envy, Ecuador, Albino A+, McKennaii — each with varying potency and growth characteristics
Contamination Prevention:
• Sterile technique is essential throughout the process
• Common contaminants include Trichoderma (green mold), cobweb mold (Dactylium), and various bacteria
• Proper pasteurization/sterilization of substrate and clean transfer environments are critical
Fun Fact
Psilocybe cubensis and its psychoactive compounds have a fascinating intersection with human history, neuroscience, and even evolutionary biology: Ancient Ritual Use: • The Mazatec people of Oaxaca, Mexico, have used Psilocybe mushrooms in sacred healing ceremonies for centuries, calling them "teonanácatl" (Nahuatl for "flesh of the gods") • Maria Sabina, a Mazatec curandera (healer), became internationally known in the 1950s after sharing her mushroom ceremony practices with Western researchers Modern Neuroscience Renaissance: • Since the early 2000s, institutions including Johns Hopkins University, Imperial College London, and NYU have conducted groundbreaking clinical trials using psilocybin • Research has shown promising results for treatment-resistant depression, end-of-life anxiety, PTSD, and addiction (alcohol and tobacco) • In 2018, the U.S. FDA granted "Breakthrough Therapy" designation to psilocybin therapy for treatment-resistant depression The Blue Bruising Mystery: • The characteristic blue bruising of Psilocybe cubensis is caused by the enzyme-mediated oxidation of psilocin (4-HO-DMT) into blue-colored quinoid oligomers • This is the same chemical family responsible for the brown discoloration of a cut apple — enzymatic oxidation of phenolic compounds • The intensity of blue bruising is sometimes used as a rough (though imprecise) visual indicator of relative potency Evolutionary Puzzle: • Why would a mushroom evolve to produce psychoactive compounds? One leading hypothesis is that psilocybin acts as an insect deterrent — disrupting serotonin signaling in invertebrates that might otherwise consume the fungus • A 2019 study published in Mycologia found that psilocybin reduces insect feeding on Drosophila melanogaster, supporting this ecological defense hypothesis Spore Dispersal: • A single mature Psilocybe cubensis fruiting body can release billions of spores over its lifespan • Spores are dispersed by wind, insects, and animals (particularly herbivores that consume the mushrooms and deposit viable spores in their dung — completing the coprophilous life cycle) • Spores can remain viable for years under proper storage conditions
Learn more
